Ocular Inflammation After Cataract Surgery

• FDA approval · 2024-07-08
  FDA Approved: BROMFENAC OPHTHALMIC SOLUTION, 0.07% — Original Application (Apotex Corp.)

  The FDA approved Apotex Corp.'s generic bromfenac ophthalmic solution 0.07% under an Original Application for relief of ocular pain and redu…

• FDA approval · 2015-07-01
  FDA Approved: BROMFENAC OPHTHALMIC SOLUTION — Supplemental Application (Bausch & Lomb Americas Inc.)

  The FDA approved a supplemental application for Bromfenac Ophthalmic Solution (bromfenac sodium) from Bausch & Lomb Americas, expanding its …

• FDA approval · 2011-06-27
  FDA Approved: NEVANAC — Supplemental Application (Harrow Eye, LLC)

  FDA approved a supplemental NDA for NEVANAC (nepafenac) submitted by Harrow Eye, LLC.